Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
Title:
Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study
Author:
Tabernero, J. Velez, L. Trevino, T.L. Grothey, A. Yaeger, R. Van Cutsem, E. Wasan, H. Desai, J. Ciardiello, F. Yoshino, T. Gollerkeri, A. Maharry, K. Christy-Bittel, J. Kopetz, S.